Bioptimus
Universal biology foundation model from ex-DeepMind team
Bioptimus is building the first universal AI foundation model for biology, aiming to create a single model that can understand and predict across the full spectrum of biological data — from genomics to histopathology to clinical records. Founded by a team of ex-DeepMind and Owkin scientists, the company rapidly achieved recognition as a CB Insights AI 100 company.
Foundation Models, Target Discovery, Platform
H-Optimus-0
Funding
$76M
Total raised
$41M
Led by Cathay Innovation
Sofinnova Partners · Cathay Innovation · Bpifrance Large Venture · Frst · Headline · Hummingbird · NJF Capital · Owkin · Xavier Niel
Technology
Building a universal foundation model for biology trained on multimodal biological data including histopathology, transcriptomics, and clinical data. H-Optimus-0 is a 1.1 billion parameter model for computational pathology.
Leadership
Jean-Philippe Vert
CEO & Co-Founder
Former Google DeepMind research scientist, Owkin Chief R&D Officer
Similar companies
Lila Sciences
Autonomous AI science factories for drug discovery
platform · 2025BenevolentAI
AI-enabled knowledge graph for drug discovery and repurposing
clinical · 2014Boltz PBC
Open-source biomolecular AI for drug discovery
platform · 2026Calico Life Sciences
Alphabet-backed research into the biology of aging
clinical · 2013Get updates on Bioptimus
We'll notify you when we publish updates about Bioptimus.